Long-term data confirm safety and efficacy of ustekinumab: The UNITI study evaluated the efficacy and safety of intravenous induction therapy with ustekinumab followed by subcutaneous maintenance therapy and an extension phase in patients with moderately to severely active Crohn’s disease.
You May Also Like
- Lymphoma
Treatment goal: slow progression, improve quality of life
- PancNEN, PancNET & PancNEC
Neuroendocrine tumors of the pancreas
- Heart failure
Interventional treatment of the tricuspid valve
- Lipoprotein(a)
Current and future treatment options
- Lichen sclerosus
Topical corticosteroids still the first choice
- Breast Cancer
On the trail of triple-negative breast cancer
- Headache treatment
The therapy of migraine
- Sleep disorders in old age